Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Radioiodine Therapy for Hyperthyroidism
source: The New England Journal of Medicine
year: 2011
authors: Douglas S. Ross
summary/abstract:A 37-year-old woman receives a diagnosis of Graves’ disease and is treated with methimazole for 1 year. After completing this treatment, she presents with recurrent symptoms of hyperthyroidism. Radioiodine ablation is recommended.
organization: Massachusetts General Hospital, USADOI: 10.1056/NEJMct1007101
read more full text
Related Content
-
Hyperthyroidism in Children and AdolescentsWhat is the Thyroid Gland? The thyroid ...
-
Hyperthyroid Patients Without Graves’ Orbitopathy are not at Increased Risk of Developing Glaucoma: A Nationwi...Purpose: Graves' disease (GD) and toxic...
-
The Brazilian Consensus for the Diagnosis and Treatment of Hyperthyroidism: Recommendations by the Thyroid Departmen...Introduction: Hyperthyroidism is charac...
-
Structural Brain Changes in Graves’ Hyperthyroidism may be of Autoimmune OriginIn Graves’ disease (GD), brain-derived...
-
Radioiodine Ablation of Postsurgical Thyroid Remnants After Treatment With Recombinant Human TSH (rhTSH) in Patients...Context: Recent evidence suggests thyro...
-
Risk Factors For Developing Thyroid-Associated Ophthalmopathy Among Individuals with Graves’ DiseaseImportance: Thyroid-associated ophthalm...
-
Clinical and Socioeconomic Factors Influence Treatment Decisions in Graves’ DiseaseBackground: Definitive treatment of Gra...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
myBinder